Budget impact analysis of Intravenous Magnesium Sulfate for Treating Asthma Exacerbations in Children
preprint
OA: closed
Abstract
Intravenous Magnesium SulfateIV was cost-saving in emergency settings for treating children with asthma exacerbations. This shift in treatment approach proved to be economically favorable, reducing the cost of hospitalization and mechanical ventilation
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00